5 things to know about Moderna’s coronavirus vaccine – Reports

The Boston-based Moderna Therapeutics released a blueprint Thursday morning outlining how it will determine if its coronavirus vaccine, which is currently under development, is effective and safe. CBS News spoke to Moderna’s president, Dr. Stephen Hoge, for the “CBS Evening News” series Racing to a Cure.

Here are our top takeaways from that conversation:

1. Moderna is working on a first-of-its-kind vaccine

The vaccine being developed by Moderna is an mRNA vaccine, which works differently…

Read Full Article

Almost all The British Journal staff, including reporters, can be contacted by e-mail. In most cases the e-mail address follows this formula: first initial + last name + @thebritishjournal.com. For example, Laura F. Nixon is [email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.